Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-03-16Clinical Trial Update: A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial of Cardene I.V. for pediatric hypertension was withdrawn from the study. No res…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Blood Pressure Self Management for Hypertension & Prehypertension Using an Internet Enabled, Automated Self Management Program [NA]
This completed clinical trial evaluated an Internet-enabled, automated self-management program for blood pressure control in people with hyp…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Weight Loss Maintenance (WLM) [NA]
This clinical trial update reports a completed study on Weight Loss Maintenance (WLM) sponsored by Duke University, focusing on obesity and …
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study) [NA]
A completed clinical trial evaluating the Be Fit, Be Well program for blood pressure reduction and weight loss. The study population is low-…
-
CLINICAL_TRIALS withdrawal · 2012-03-06Clinical Trial Update: Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan [Phase 4]
A Phase 4 trial comparing amlodipine and aliskiren in diabetic patients with hypertension not controlled by losartan has been withdrawn. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial evaluating the effects of an exercise program in patients with hypertensive chronic kidney disease; current status …
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Effect of Continuous Positive Airway Pressure (CPAP) Treatment in the Control of Refractory Hypertension [NA]
This completed trial evaluated whether Continuous Positive Airway Pressure (CPAP) therapy improves control of refractory hypertension in peo…
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Clinical Decision Support Consortium [NA]
ClinicalTrials.gov update for the Clinical Decision Support Consortium; it lists diabetes, coronary artery disease, and hypertension as cond…
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Treatment of Adiposity Related hypErTension (TARGET) [Phase 4]
The TARGET Phase 4 trial on treatment of adiposity-related hypertension (sponsored by UMC Utrecht) has completed, addressing hypertension, a…
-
FDA approval · 2012-02-23FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Dr. Reddy's Laboratories' fixed-dose combination of amlodipine besylate and benazepril hydrochlo…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: The Impact of Yoga on Blood Pressure and Quality of Life in Patients With Hypertension [NA]
A completed clinical trial investigated the impact of yoga on blood pressure and quality of life in patients with hypertension.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients [Phase 4]
Phase 4 trial update reports results from a benidipine-based comparison in hypertensive patients, evaluating combinations with angiotensin r…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Internet-Based Strategic Transdisciplinary Approach To Risk Reduction And Treatment [Phase 2, Phase 3]
This clinical trial update notes the completion of Phase 2 and Phase 3 for an internet-based risk reduction and treatment strategy in hypert…
-
FDA approval · 2012-02-17FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) from Bausch Health US, LLC. The action per…
-
FDA approval · 2012-02-17FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves the original application for Losartan Potassium and Hydrochlorothiazide combination tablets from Alembic Pharmaceuticals Limite…
-
FDA label_change · 2012-02-17FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
The FDA approved a supplemental application for enalapril maleate (Oceanside Pharmaceuticals), resulting in a labeling update for the produc…
-
FDA approval · 2012-02-16FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental NDA for Benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC).
-
FDA approval · 2012-02-16FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for DIOVAN HCT (valsartan/hydrochlorothiazide) from Novartis Pharmaceuticals Corporation.
-
FDA label_change · 2012-02-16FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
A supplemental application for Exforge HCT (amlodipine, valsartan, and hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporatio…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension [NA]
A completed clinical trial evaluating the effectiveness of Viscum album mother tincture as an anti-hypertensive in essential hypertension.
-
FDA approval · 2012-02-15FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' supplemental application for Benicar (olmesartan medoxomil), resulting in an approved update to th…
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Nijmegen Antihypertensive Management Improvement Study [Phase 4]
Phase 4 trial evaluating antihypertensive management strategies for primary hypertension. The study conducted by Radboud University Medical …
-
FDA approval · 2012-02-09FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) from Sanofi-Aventis U.S. LLC. This action represent…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of azilsartan medoxomil in combination with chlorthalidone for moderate to severe hypertens…
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension [Phase 4]
Phase 4 clinical trial evaluating the effect of moxonidine on blood pressure. The study also assesses regression of early target organ damag…